Back

dr. Z. Sebestyen

dr. Z. Sebestyen

Associate Professor

Show full profile

Research Output (28)

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

de Bruin Renée C G, Veluchamy John P., Lougheed Sinéad M, Schneiders Famke L., Lopez-Lastra Silvia, Lameris Roeland, Stam Anita G M, Sebestyen Zsolt, Kuball Jürgen, Molthoff Carla F M, Hooijberg Erik, Roovers Rob C., Santo James P.Di, van Bergen En Henegouwen Paul M P, Verheul Henk M. W., de Gruijl Tanja D, van Vliet Hans J 2017, In: OncoImmunology. 7 , p. e1375641

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

Sebestyen Zsolt, Scheper Wouter, Vyborova Anna, Gu Siyi, Rychnavska Zuzana, Schiffler Marleen, Cleven Astrid, Chéneau Coraline, van Noorden Martje, Peigné Cassie-Marie, Olive Daniel, Lebbink Robert Jan, Oostvogels Rimke, Mutis Tuna, Schuurhuis Gerrit Jan, Adams Erin J, Scotet Emmanuel, Kuball Jürgen 2016, In: Cell Reports [E]. 15 , p. 1973-1985 13 p.

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Drent Esther, Groen Richard W.J., Noort Willy A, Themeli Maria, Lammerts van Bueren Jeroen J, Parren Paul W H I, Kuball Jürgen, Sebestyen Zsolt, Yuan Huipin, de Bruijn Joost, van de Donk Niels W C J, Martens Anton C M, Lokhorst Henk M, Mutis Tuna 2016, In: Haematologica. 101 , p. 616-625 10 p.

Untouched GMP-ready purified engineered immune cells to treat cancer

Straetemans Trudy, Gründer Cordula, Heijhuurs Sabine, Hol Samantha, Slaper-Cortenbach Ineke, Bönig Halvard, Sebestyen Zsolt, Kuball Jürgen 1 Sep 2015, In: Clinical Cancer Research. 21 , p. 3957-3968 12 p.

Hunting for clinical translation with innate-like immune cells and their receptors

Scheper W, Gründer C, Straetemans T, Sebestyen Z, Kuball J Jun 2014, In: Leukemia. 28 , p. 1181-1190 10 p.

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.

Scheper W.A., Sebestyen Z., Kuball J.H.E. 2014, In: Frontiers in Immunology [E]. 5 , p. 601-601 1 p.

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs.

Grunder E.C., van Dorp S., Hol S., Drent E., Straetemans T., Heijhuurs S., Scholten K.B.J., Scheper W., Sebestyen Z., Martens A.C.M., Strong R., Kuball J.H.E. 2012, In: Blood. 120 , p. 5153-5162 10 p.

Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor

Marcu - Malina V., Heijhuurs S., van Buuren extern, Hartkamp L.M., Strand S., Sebestyen Z., Scholten K.B.J., Martens A.C.M., Kuball J.H.E. 2011, In: Blood. 118 , p. 50-59 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not